Researchers uncover potential risks of beta-interferon treatment for MS on: May 18, 2017, 04:38:01 pm #1 A University of British Columbia study has revealed increased risks for stroke, migraine, depression and blood abnormalities in people with MS taking beta-interferons:QuoteThe study aimed to identify potential adverse events related to beta-interferon treatment for relapsing-remitting multiple sclerosis by analyzing health records of over 2,000 British Columbians with multiple sclerosis between 1995 and 2008.The article, "Researchers uncover potential risks of common MS treatment," in Medical News Today (May 17) is available here: Researchers uncover potential risks of common MS treatment In one of the most comprehensive studies to date, UBC researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug. Medical News Today · medicalnewstoday.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
